Bio

Has more than 25 years experience as Regulatory Affairs, Quality Assurance and Clinical Trial Director of pharmaceutical and medical device companies (Head Pharmacist). Has joined MERIEUX DEVELOPPEMENT on May 2014 as Partner to develop investments in European and American MedTech companies, both early and late stage (small and mid cap), in Health and Nutrition sectors (human and animal). From 2006-2014, as Partner in Matignon Investissement et Gestion, has invested in MedTech companies (primarily Europe but not exclusively), helping the management to develop their products and gain access to international markets, and support late stage M&A or IPO. Previously worked as Director for Quintiles Consulting Europe, where he combined technical, regulatory, quality and business expertise with practical know-how for European health care regulations. In addition has been working for more than 5 years as an Expert of the Commission of the European Union for MedTech regulations. Chairman of the EUCOMED Task Force on human tissue/cell products in Europe and also chaired working groups in CEN (Commission Européenne de Normalisation) and ISO (International Standard Organisation) for the publication of harmonized standards on risk analysis and management of medical devices utilizing animal material. He was also an Expert for the French Agency for Health Care Products (AFSSaPS) Board Directors in several European MedTech companies: Anteis, ART, AirInSpace, Mapi, Medicrea (listed company), Nanobiotix (listed company), Orteq, Visiomed (listed company). Specialties: Assess BP in Medical Technologies (preclinical, clinical, regulations, market access) Understanding of Healthcare policies and regulatory compliance Investing in MedTech companies